UNITED STATES |
SECURITIES AND EXCHANGE COMMISSION |
Washington, D.C. 20549 |
FORM 8-K |
Current Report |
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 |
Date of Report (date of earliest event reported): December 11, 2013 |
ENERTOPIA CORP. |
(Exact name of registrant as specified in its charter) |
Nevada | 000-51866 | 20-1970188 |
(State or other jurisdiction | (Commission | (IRS Employer |
of incorporation) | File Number) | Identification No.) |
#950 1130 West Pender Street, Vancouver, British Columbia, Canada V6E 4A4 |
(Address of principal executive offices) (Zip code) |
Registrant's telephone number, including area code: (604) 602-1675 |
_______________________________________________ |
(Former name or former address, if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
[ ] Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425)
[ ] Soliciting material pursuant to Rule
14a-12 under the Exchange Act (17 CFR 240.14a -12)
[ ] Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d
-2(b))
[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under
Exchange Act (17 CFR 240.13e -4(c))
Item 7.01 Regulation FD Disclosure
On December 11, 2013, the Company announced that the private Canadian medical marihuana producer has submitted all the required paperwork for a site visit by Health Canada.
A copy of the news release is filed as exhibit 99.1 to this current report and is hereby incorporated by reference.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits.
Exhibit No. | Description |
99.1 | Press Release dated December 11, 2013. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Dated: December 11, 2013
Enertopia Corp. | |
By: ____Robert McAllister______ | |
Robert G. McAllister | |
CEO and President and Director |